Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Late results of a randomized trial on the role of mild hypofractionated radiotherapy for the treatment of localized prostate cancer.
Alexidis P, Karatzoglou S, Dragoumis D, Drevelegas K, Tzitzikas I, Hatzimouratidis K, Chrisogonidis I, Ioannidis A, Katsios IN, Zarogoulidis P, Sapalidis K, Koulouris C, Michalopoulos N, Giannakidis D, Aidoni Z, Fyntanidou V, Amaniti A, Boniou K, Kesisoglou I, Vagionas A, Romanidis K, Oikonomou P, Goganau AM, Petanidis S, Maragouli E, Kosmidis C. Alexidis P, et al. Among authors: maragouli e. J Cancer. 2020 Jan 1;11(5):1008-1016. doi: 10.7150/jca.37825. eCollection 2020. J Cancer. 2020. PMID: 31956347 Free PMC article.
The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial.
Alexidis P, Dragoumis D, Karatzoglou S, Drevelegas K, Tzitzikas I, Hatzimouratidis K, Chrisogonidis I, Giannakidis D, Koulouris C, Katsaounis A, Michalopoulos N, Huang H, Li Q, Aidoini Z, Fyntanidou V, Amaniti A, Hohenforst-Schmidt W, Maragouli E, Petanidis S, Zarogoulidis P, Sapalidis K, Kosmidis C, Romanidis K, Oinkonomou P, Vagionas A, Nikolaos-Katsios I, Ioannidis A, Boniou K, Kesisoglou I. Alexidis P, et al. Among authors: maragouli e. J Cancer. 2019 Oct 16;10(25):6217-6224. doi: 10.7150/jca.35510. eCollection 2019. J Cancer. 2019. PMID: 31772654 Free PMC article.
EBUS-TNBA 22G samples: Comparison of PD-L1 expression between DAKO and BIOCARE®.
Sapalidis K, Zarogoulidis P, Petridis D, Kosmidis C, Fyntanidou B, Tsakiridis K, Maragouli E, Amaniti A, Giannakidis D, Koulouris C, Mantalobas S, Katsaounis A, Alexandrou V, Koimtzis G, Pavlidis E, Barmpas A, Tsiouda T, Sardeli C, Aidoni Z, Huang H, Li Q, Hohenforst-Schmidt W, Kesisoglou I. Sapalidis K, et al. Among authors: maragouli e. J Cancer. 2019 Aug 20;10(20):4739-4746. doi: 10.7150/jca.35898. eCollection 2019. J Cancer. 2019. PMID: 31598145 Free PMC article.
EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50.
Zarogoulidis P, Chinelis P, Efthymiou C, Athanasiadou A, Mpikos V, Papatsibas G, Papadopoulos V, Maragouli E, Huang H, Trakada G, Kallianos A, Veletza L, Hohenforst-Schmidt W. Zarogoulidis P, et al. Among authors: maragouli e. Respir Med Case Rep. 2017 May 30;22:7-10. doi: 10.1016/j.rmcr.2017.05.010. eCollection 2017. Respir Med Case Rep. 2017. PMID: 28761805 Free PMC article.